These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia. Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321 [TBL] [Abstract][Full Text] [Related]
25. Various effects of antipsychotics on P50 sensory gating in Chinese schizophrenia patients: a meta-analysis. Su L; Cai Y; Wang L; Shi S Psychiatr Danub; 2012 Mar; 24(1):44-50. PubMed ID: 22447085 [TBL] [Abstract][Full Text] [Related]
26. The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels. Ucar E; Lehtinen EK; Glenthøj BY; Oranje B J Psychopharmacol; 2012 Aug; 26(8):1113-8. PubMed ID: 22331175 [TBL] [Abstract][Full Text] [Related]
27. Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry. Csomor PA; Preller KH; Geyer MA; Studerus E; Huber T; Vollenweider FX Neuropsychopharmacology; 2014 Sep; 39(10):2485-96. PubMed ID: 24801767 [TBL] [Abstract][Full Text] [Related]
28. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia. Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264 [TBL] [Abstract][Full Text] [Related]
29. Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication. Oranje B; Glenthøj BY Schizophr Bull; 2014 Sep; 40(5):1022-9. PubMed ID: 24106334 [TBL] [Abstract][Full Text] [Related]
30. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia]. Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782 [TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of auditory P50 sensory gating in schizophrenia and bipolar disorder. Atagun MI; Drukker M; Hall MH; Altun IK; Tatli SZ; Guloksuz S; van Os J; van Amelsvoort T Psychiatry Res Neuroimaging; 2020 Jun; 300():111078. PubMed ID: 32361172 [TBL] [Abstract][Full Text] [Related]
32. Olanzapine effects on auditory sensory gating in schizophrenia. Arango C; Summerfelt A; Buchanan RW Am J Psychiatry; 2003 Nov; 160(11):2066-8. PubMed ID: 14594761 [TBL] [Abstract][Full Text] [Related]
33. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia. Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073 [TBL] [Abstract][Full Text] [Related]
34. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects. Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399 [TBL] [Abstract][Full Text] [Related]
35. Spectral decomposition of P50 suppression in schizophrenia during concurrent visual processing. Moran ZD; Williams TJ; Bachman P; Nuechterlein KH; Subotnik KL; Yee CM Schizophr Res; 2012 Sep; 140(1-3):237-42. PubMed ID: 22840844 [TBL] [Abstract][Full Text] [Related]
36. The effects of increased serotonergic activity on human sensory gating and its neural generators. Jensen KS; Oranje B; Wienberg M; Glenthøj BY Psychopharmacology (Berl); 2008 Mar; 196(4):631-41. PubMed ID: 18000656 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors. Knott VJ; Fisher DJ; Millar AM Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194 [TBL] [Abstract][Full Text] [Related]
38. Distinct neural generators of sensory gating in schizophrenia. Williams TJ; Nuechterlein KH; Subotnik KL; Yee CM Psychophysiology; 2011 Apr; 48(4):470-8. PubMed ID: 20735757 [TBL] [Abstract][Full Text] [Related]
39. Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker. Hashimoto K Curr Pharm Des; 2015; 21(26):3797-806. PubMed ID: 26044974 [TBL] [Abstract][Full Text] [Related]
40. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]